: "arise: a phase 3 randomized trial of erenumab for episodic migraine.".
.
now the country may face a fine of millions of euros after its dereliction was referred to the european court of justice (ecj), the guardian reports...
for advertisers.
the state launched a review into the newspaper’s findings in late april.